$CROX

Rees Andrew sold $4.2M of CROX (indirect holdings)

Rees Andrew (Chief Executive Officer) sold 30,000 indirectly-held shares of Crocs, Inc. (CROX) at an average of $138.49 ($137.41–$140.02, $4.15M total) across 6 trades over 2026-08-07 to 2026-08-10.

Original reporting
SEC EDGAR · Rees Andrew
Published Aug 11, 2026, 3:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 3:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CROX
Neutral
medium confidence
Mentioned
$CROX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CROXNeutralLow
01

Why it matters

The newest information is the specific open-market sale details (shares, dates, price range, and total value) disclosed in the filing. It may influence short-term sentiment but does not provide new operating or financial guidance.

02

Market read

Traders may briefly reassess CROX sentiment due to a CEO sale, but the disclosure lacks fundamental catalysts.

03

What to watch

Because the filing states indirect holdings and does not cite a 10b5-1 plan, traders may over-weight it; confirm whether other insiders filed contemporaneous transactions or whether there is a broader pattern.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-11, after-hours/near close disclosure window

Background

The article is an SEC Form 4 insider transaction disclosure for Crocs, Inc. (CROX) by CEO Andrew Rees.

Company-level read

Ticker impact

$CROXNeutralMedium confidence
Context

Crocs CEO Andrew Rees sold about 30,000 shares in open-market trades for roughly $4.15M, per a new SEC Form 4 filed today.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if additional filings or company-specific news appear.

Evidence & confidence

The filing provides transaction size, dates, and pricing range, but it does not include new earnings, guidance, or operational/regulatory developments. Insider sales can be interpreted as liquidity or diversification, and the absence of a stated 10b5-1 plan adds some uncertainty.

Market effects

Minimal; insider-sale filings rarely reset sector expectations without accompanying company fundamentals.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or tax-related, and the disclosed price range suggests execution across multiple days rather than a single panic move.

Key entities

  • Crocs, Inc.

    US-listed footwear company subject of the Form 4 insider transaction disclosure.

  • Andrew Rees

    Chief Executive Officer and director who sold shares via open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CROXMedAI 8/10

Crocs (CROX) Q2 2026 Earnings Call Transcript

Crocs (CROX) reported Q2 2026 enterprise revenue of $1.179B, up 2.0% constant currency, with Crocs brand revenue at $1.0B and HEYDUDE at $179M. Adjusted diluted EPS was $4.55. Gross margin fell to 60.0% due to tariff impacts. FY2026 guidance and EPS were raised, alongside a $1.5B share repurchase authorization.